Bristol Myers Squibb has the first positive phase 3 results under its belt for mezigdomide, a second experimental drug in its much-trumpeted celmod development programme for multiple myeloma. Interim ...

Batteries are notoriously difficult pieces of technology to deal with reliably. They often need specific temperatures, charge ...

In brief: A few months after acquiring Arduino, Qualcomm is introducing its first product designed to combine its processor technology with the "maker" ethos of the Italian company. Unsurprisingly, ...

Five months after acquiring Arduino, the open-source hardware and software company best known for its UNO and Nano microcontroller board for hobbyists, Qualcomm is looking to make another big splash ...

Bristol Myers Squibb (NYSE: BMY; BMS) delivered some good news to investors in reporting fourth-quarter and full-year 2025 results on Thursday. The pharma giant beat analyst consensus forecasts by ...

Bristol Myers Squibb hasn’t had much luck with its efforts to develop cancer treatments called T cell engagers. But the pharmaceutical company isn’t done pursuing this type of targeted cancer therapy, ...

The future of electric vehicles depends on battery packs that are safe, efficient, and easy to maintain. Wireless battery-management systems introduce a new way to cover all of these needs. What’s the ...

Forbes contributors publish independent expert analyses and insights. Chief Analyst & CEO, NAND Research. Qualcomm, a company built on selling chips to companies like Samsung and Apple in volumes of ...

In a deal that surprised some industry observers, chipmaker Qualcomm has agreed to buy Arduino, which is best known for supplying microcontrollers to the DIY community. The acquisition, whose terms ...

Qualcomm announced Tuesday it will acquire Arduino for undisclosed terms. The chipmaker said the Italy-based company would become an independent subsidiary of Qualcomm. In this article Qualcomm wants ...

Smartphone processor and modem maker Qualcomm is acquiring Arduino, the Italian company known mainly for its open source ecosystem of microcontrollers and the software that makes them function. In its ...

Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...